Table 2 Laboratory characteristics and biopsy sampling of study population
|  | AIH (n = 160) | PBC (n = 37) | PSC (n = 20) | Overlap syndrome (OS) (n = 48) |
|---|---|---|---|---|
ANA | 67 (41.9%) | 7 (18.9%) | 2 (10.0%) | 13 (27.1%) |
ASMA | 21 (13.1%) | 1 (2.7%) | 3 (15.0%) | 11 (22.9%) |
AMA | 7 (4.4%) | 25 (67.6%) | 1 (5.0%) | 7 (14.6%) |
Anti-LKM1 | 5 (3.1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Anti-dsDNA | 7 (4.4%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Liver Biopsy | 121 (75.6%) | 24 (64.8%) | 12 (60%) | 34 (70%) |